🔎 Trials Near Me

Akèy › Timè nan sèvo › Oregon › Portland

Etid klinik pou Timè nan sèvo nan Portland, OR

8 etid pou Timè nan sèvo ap chèche patisipan nan sit nan ak bò kote Portland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Ap rekriteFaz 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04511013

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Ap rekriteFaz 2
  • OHSU Knight Cancer Institute, Portland
Laj 10 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT03270059

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Ap rekriteFaz 1
  • Providence Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06253871

An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregivers, ET-NEURO Trial

Ap rekriteVolontè an sante akeyi
  • OHSU Knight Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07278440

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Ap rekriteFaz 3
  • Oregon Health & Science University, Portland
Laj 18 a 100 · Tout sèks · Mizajou Aug 19, 2026 · NCT05317858

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Ap rekriteFaz 3
  • Legacy Good Samaritan Hospital and Medical Center, Portland
Laj 18 ak plis · Tout sèks · Mizajou Jun 9, 2026 · NCT03550391

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Oregon Health Sciences University, Portland
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Ap rekriteFaz 3
  • Kaiser Permanente Northwest, Portland
  • Oregon Health and Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Oct 8, 2025 · NCT03418961

Etid Timè nan sèvo nan lòt vil

Lòt etid nan Portland

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.